Applied DNA Sciences, Inc.

PRESS RELEASE

published on 12/14/2023 at 14:00, 11 months 7 days ago

Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
PRESS RELEASE

published on 12/07/2023 at 22:05, 11 months 13 days ago

Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
PRESS RELEASE

published on 12/05/2023 at 14:30, 11 months 16 days ago

Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
Applied DNA Sciences, Inc. (NASDAQ:APDN) will release its Q4 and full year 2023 financial results on December 7, 2023, after the market close. A conference call for investors will follow to discuss the results

Financial Results Conference Call Investor Relations Applied DNA Sciences NASDAQ:APDN
PRESS RELEASE

published on 11/28/2023 at 14:30, 11 months 23 days ago

Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
PRESS RELEASE

published on 11/16/2023 at 14:30, 1 year ago

Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
PRESS RELEASE

published on 11/09/2023 at 15:15, 1 year ago

Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform
PRESS RELEASE

published on 09/14/2023 at 15:00, 1 year 2 months ago

Applied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
PRESS RELEASE

published on 09/06/2023 at 15:00, 1 year 2 months ago

Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
PRESS RELEASE

published on 08/29/2023 at 15:00, 1 year 2 months ago

Applied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit
PRESS RELEASE

published on 08/23/2023 at 15:30, 1 year 2 months ago

Applied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production

Published on 11/21/2024 at 17:35, 20 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 25 minutes ago

SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 1 hour 25 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 54 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 55 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight

View all ACCESSWIRE

Published on 11/21/2024 at 16:00, 1 hour 55 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 2 hours 13 minutes ago

Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 2 hours 31 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 2 hours 32 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 2 hours 33 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc

View all EQS

Published on 11/21/2024 at 06:58, 10 hours 57 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 22 hours 35 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 10 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE

News